Tumors were classified into four categories based on mutation burden: high NUSAP+ Glioma score with high TMB, high NUSAP+ Glioma score with low TMB, low NUSAP+ Glioma score with high TMB, and low NUSAP+ Glioma score with low TMB. Here, NUSAP1 is linked to central nervous system cancer.